Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-05-12 @ 10:59 AM
Study NCT ID:
NCT04306705
Status:
UNKNOWN
Last Update Posted:
2020-03-17
First Post:
2020-03-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19
Sponsor:
Tongji Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
WHTJCOVID-19
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None